No record found


* Returns not adjusted for payouts
Company Profile
Haleon Pakistan Limited (formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited) was incorporated in Pakistan as a public listed company under the provisions of the repealed Companies Ordinance, 1984 (now Companies Act, 2017) on 31 March 2015. The Company is a subsidiary of ‘Haleon Netherlands B.V’. The ultimate parent of the Company is Haleon plc. The Company is inter alia principally engaged in the manufacturing, marketing and sale of consumer healthcare and over the counter health products.
Farhan Muhammad Haroon | CEO |
Mashal Mohammad | Company Secretary |
Muhammad Zindah Moin Mohajir | Chairperson |
11-A, 11th Floor, Sky Tower (East Wing), Dolmen City, HC-3, Block 4, Scheme-5, Clifton, Karachi, 75600
CDC Share Registrar Services Limited CDC House, Main Shahrah-e-Faisal, Karachi.
M/s KPMG Taseer Hadi & Co. Chartered Accountants
December
Equity Profile
Announcements
Date | Title | Document |
---|---|---|
Aug 29, 2023 | Transmission of Half Yearly Report for the Period Ended 30 June 2023 | View PDF |
Aug 22, 2023 | Financial Results for the Quarter Ended 30 June 2023 | View PDF |
Apr 27, 2023 | Transmission of Quarterly Report for the Period Ended 31 March 2023 | View PDF |
Apr 27, 2023 | Financial Results for the Quarter Ended 31 March 2023 | View PDF |
Apr 6, 2023 | Transmission of Annual Report for the Year Ended 2022 | View PDF |
Mar 15, 2023 | Financial Results for the Year Ended 31 December 2022 | View PDF |
Date | Title | Document |
---|---|---|
Aug 11, 2023 | Notice of Board of Directors Meeting - (Q2-2023) | View PDF |
Apr 27, 2023 | CTC of Resolutions Passed in the Annual General Meeting 2022 | View PDF |
Apr 26, 2023 | Board Meeting In Progress | View PDF |
Apr 18, 2023 | Notice of Board of Directors Meeting - (Q1-2023) | View PDF |
Apr 6, 2023 | Notice of Annual General Meeting | View PDF |
Apr 5, 2023 | Prior Publication of Annual General Meeting Notice | View PDF |
Mar 14, 2023 | Board Meeting in Progress | View PDF |
Mar 6, 2023 | Notice of Board of Directors Meeting - (Q4-2022) | View PDF |
Date | Title | Document |
---|---|---|
Sep 12, 2023 | Change of Company Website | View PDF |
Jun 14, 2023 | Reminder for Mandatory Conversion of Physical Shares to Book-Entry Form | View PDF |
Jun 13, 2023 | Prior Publication of Conversion of Physical Shares to Book Entry Form | View PDF |
Apr 27, 2023 | Appointment / Change of External Auditors | View PDF |
Mar 6, 2023 | Change of Name of Parent Company | View PDF |
Feb 9, 2023 | Change in Registered Office Address | View PDF |
Financials
All numbers in thousands (000's) except EPS
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
Sales | 27,507,212 | 24,163,150 | 19,846,106 | 16,316,745 |
Profit after Taxation | 325,411 | 2,134,334 | 1,262,009 | 1,257,519 |
EPS | 2.78 | 18.23 | 10.78 | 10.74 |
Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | |
---|---|---|---|---|
Sales | 7,841,482 | 7,820,947 | 6,593,614 | 7,087,103 |
Profit after Taxation | 9,925 | 303,139 | (345,213) | (279,313) |
EPS | 0.08 | 2.59 | (2.95) | (2.39) |

Ratios
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
Gross Profit Margin (%) | 17.40 | 27.38 | 26.85 | 30.56 |
Net Profit Margin (%) | 1.18 | 8.83 | 6.36 | 7.71 |
EPS Growth (%) | (84.75) | 69.11 | 0.37 | 16.99 |
PEG | (0.70) | 0.19 | 66.04 | 1.40 |